Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Centre selection for clinical trials and the generalisability of results: a mixed methods study.

Gheorghe A, Roberts TE, Ives JC, Fletcher BR, Calvert M.

PLoS One. 2013;8(2):e56560. doi: 10.1371/journal.pone.0056560. Epub 2013 Feb 22. Review.

2.

Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index.

Gheorghe A, Roberts T, Hemming K, Calvert M.

Pharmacoeconomics. 2015 Nov;33(11):1195-214. doi: 10.1007/s40273-015-0298-3.

PMID:
26068945
3.

Rational centre selection for RCTs with a parallel economic evaluation--the next step towards increased generalisability?

Gheorghe A, Roberts T, Pinkney TD, Morton DG, Calvert M.

Health Econ. 2015 Apr;24(4):498-504. doi: 10.1002/hec.3039. Epub 2014 Feb 13.

PMID:
24523070
4.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

5.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

6.

Bone graft substitutes for the treatment of traumatic fractures of the extremities.

Hagen A, Gorenoi V, Schönermark MP.

GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.

7.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

8.

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.

Naumann-Winter F, Greb A, Borchmann P, Bohlius J, Engert A, Schnell R.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD004626. doi: 10.1002/14651858.CD004626.pub3. Review.

PMID:
23076906
9.

Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.

Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, Royle P, Davidson P, Vale L, MacKenzie L.

Health Technol Assess. 2005 May;9(17):1-99, iii-iv. Review.

10.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

11.

Identification and assessment of ongoing trials in health technology assessment reviews.

Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, Hyde C.

Health Technol Assess. 2004 Nov;8(44):iii, 1-87. Review.

12.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

13.

Risperidone dose for schizophrenia.

Li C, Xia J, Wang J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007474. doi: 10.1002/14651858.CD007474.pub2. Review.

PMID:
19821422
14.

Falls prevention for the elderly.

Balzer K, Bremer M, Schramm S, Lühmann D, Raspe H.

GMS Health Technol Assess. 2012;8:Doc01. doi: 10.3205/hta000099. Epub 2012 Apr 12.

15.

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Health Technol Assess. 2001;5(1):1-137. Review.

16.

Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Weisberg HI, Hayden VC, Pontes VP.

Clin Trials. 2009 Apr;6(2):109-18. doi: 10.1177/1740774509102563.

PMID:
19342462
17.

Evaluating non-randomised intervention studies.

Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group.

Health Technol Assess. 2003;7(27):iii-x, 1-173. Review.

18.

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies.

Revicki DA, Frank L.

Pharmacoeconomics. 1999 May;15(5):423-34. Review.

PMID:
10537960
19.

Surgery for epilepsy.

West S, Nolan SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R.

Cochrane Database Syst Rev. 2015 Jul 1;(7):CD010541. doi: 10.1002/14651858.CD010541.pub2. Review.

PMID:
26130264
20.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644

Supplemental Content

Support Center